| | | 67773 | | 10.12.2020 | | Vertex Pharmaceuticals (CH) GmbH | | | | | | | | | | | | | 03.99. | | | | 03.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Trikafta 100 mg / 50 mg / 75 mg, 150 mg | Filmtabletten | Coated tablets (Filmtablette Morgendosis (Elexacaftorum 100 mg / Tezacaftorum 50 mg / Ivacaftorum 75 Mg): Elexacaftorum 100 mg, Tezacaftorum 50 mg, Ivacaftorum 75 mg) + Coated tablets (Filmtablette Abenddosis (Ivacaftorum 150 Mg): Ivacaftorum 150 mg) | R07AX32 | CI | | 02 | Trikafta 50 mg / 25 mg / 37.5 mg, 75 mg | Filmtabletten | Coated tablets (Filmtablette Morgendosis (Elexacaftorum 50 mg / Tezacaftorum 25 mg / Ivacaftorum 37.5 Mg): Elexacaftorum 50 mg, Tezacaftorum 25 mg, Ivacaftorum 37.5 mg) + Coated tablets (Filmtablette Abenddosis (Ivacaftorum 75 Mg): Ivacaftorum 75 mg) | R07AX32 | CI |
|
|
